Search for a report

NORTH AMERICA OPHTHALMOLOGY DRUGS AND DEVICES MARKET FORECAST 2018-2026

  • You are here:
  • Home
  • Downloads
  • NORTH AMERICA OPHTHALMOLOGY DRUGS AND DEVICES MARKET FORECAST 2018-2026

NORTH AMERICA OPHTHALMOLOGY DRUGS AND DEVICES MARKET FORECAST 2018-2026

The North America ophthalmology drugs and devices market holds a high growth potential for the near future due to factors like rising geriatric population, increase in strategic initiatives by large market players present in the region and increasing prevalence of ocular diseases. Over the forecast period of 2018-2026, the North America ophthalmology drugs and device market is expected to witness a CAGR of 5.91%.

NORTH AMERICA  OPTHALMOLOGY DRUGS AND DEVICES MARKET FORECAST 2018-2026

North America Ophthalmology Drugs & Devices Market Is Segmented by Ophthalmic Devices(Diagnostic & Monitoring Equipment, Surgery Device) by Vision Care(Contact Lens, Spectacles, Eye Exams) by Ophthalmic Drugs( by Prescription Type, by Drug Delivery Types, by Type of Disease, by Therapeutics) by End User(Hospitals, Eye Clinics, Diagnostic Centers, Patients) & Geography.

Request free sample

The North America ophthalmology drugs and devices market holds a high growth potential for the near future due to factors like rising geriatric population, increase in strategic initiatives by large market players present in the region and increasing prevalence of ocular diseases. Over the forecast period of 2018-2026, the North America ophthalmology drugs and device market is expected to witness a CAGR of 5.91%.

The United States and Canada are the key markets in this region. The US ophthalmology drugs and devices market has significant growth opportunities. The country has the world’s leading healthcare infrastructure and technologies, thus enabling it to manufacture ophthalmology drugs economically. The Canada ophthalmology drugs and device market is progressing on the same line. The growth in the Canada region is majorly influenced by increasing innovations in the ophthalmology market, rising prevalence of eye diseases, and increasing elderly population.

Eminent companies in the ophthalmology drugs and device market include Pfizer, GlaxoSmithKline, Santen Pharmaceutical Co Ltd, Johnson & Johnson Inc, Allergan Inc, Valent Pharmaceuticals International Inc, Bayer, Ziemer Group Holding Ag, Roche Holding Ag, and Novartis International Ag.

 

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.


    1. RESEARCH SCOPE
      • STUDY GOALS
      • SCOPE OF THE MARKET STUDY
      • WHO WILL FIND THIS REPORT USEFUL?
      • STUDY AND FORECASTING YEARS
    2. RESEARCH METHODOLOGY
      • SOURCES OF DATA
        • SECONDARY DATA
        • PRIMARY DATA
      • TOP DOWN APPROACH
      • BOTTOM-UP APPROACH
      • DATA TRIANGULATION
    3. EXECUTIVE SUMMARY
      • MARKET SUMMARY
      • KEY FINDINGS
        • VISION CARE DEVICES ARE DOMINATING THE MARKET
        • GLAUCOMA DRUGS ARE MAJORLY USED
        • RISING PREVALENCE OF EYE RELATED DISEASES
    1. MARKET DETERMINANTS
      • MARKET DRIVERS
        • INCREASING PREVALENCE OF DIABETES INCREASES THE PROBABILITY OF OPHTHALMIC DISORDERS
        • TECHNOLOGICAL ADVANCEMENT
        • INCREASE IN HEALTHCARE EXPENDITURE
      • MARKET RESTRAINTS
        • RENOWNED DRUGS GOING OFF-PATENT
        • DELAY IN DRUG APPROVALS
        • AWARENESS RELATED TO OPHTHALMOLOGY DRUGS ARE LOW
      • MARKET OPPORTUNITIES
        • INCREASE IN DISORDER SYMPTOM AND IMPROVED DIAGNOSIS LEADING TO HIGHER TREATMENT RATES
        • INCREASING DEMAND FOR INTRAOCULAR LENSES AND PHACOEMULSIFICATION DEVICES
      • MARKET CHALLENGES
        • VARIOUS RISK AND COMPLICATIONS ASSOCIATED WITH THE TREATMENT OF OCULAR DISEASES
    1. MARKET SEGMENTATION
      • MARKET BY DRUGS AND DEVICES 2018-2026
        • DEVICES
          • DIAGNOSTIC & MONITORING EQUIPMENT
            • OPTICAL COHERENCE TOMOGRAPHY
            • OPHTHALMIC ULTRASOUND IMAGING SYSTEMS
            • FUNDUS CAMERA MARKET
            • OPHTHALMOSCOPES
            • RETINOSCOPE
            • PACHYMETER
            • WAVEFRONT ABERROMETERS
            • PERIMETERS/VISUAL FIELD ANALYZER
            • AUTOREFRACTORS/PHOROPTER
            • SPECULAR MICROSCOPE
            • CORNEAL TOPOGRAPHERS
            • OTHER DIAGNOSTIC & MONITORING EQUIPMENT MARKET
          • SURGERY DEVICE
            • CATARACT SURGERY DEVICES
            • GLAUCOMA SURGERY DEVICES
            • REFRACTIVE SURGERY DEVICES
            • VITREORETINAL SURGERY DEVICES
          • VISION CARE
        • DRUGS
          • GLAUCOMA DRUG
          • RETINAL DISORDER DRUG
          • DRY EYE DRUG
          • ALLERGIC CONJUNCTIVITIS, INFLAMMATION AND CONJUNCTIVITIS DRUG
    1. KEY ANALYTICS
      • PORTER’S FIVE FORCES ANALYSIS
        • BARGAINING POWER OF BUYERS
        • BARGAINING POWER OF SUPPLIER
        • THREATS OF NEW ENTRANTS
        • THREATS OF SUBSTITUTES
        • COMPETITIVE RIVALRY
      • VALUE CHAIN ANALYSIS
        • RESEARCH AND DEVELOPMENT
        • MANUFACTURING
        • DISTRIBUTORS
        • END USERS
      • KEY BUYING CRITERIA
        • COST
        • EFFICACY
        • ACCESSIBILITY
        • INNOVATION
      • SUPPLY CHAIN ANALYSIS
        • SUPPLIERS
        • MANUFACTURERS
        • DISTRIBUTORS AND RETAILERS
        • END USERS
      • REGULATORY FRAMEWORK
    2. GEOGRAPHICAL ANALYSIS
      • NORTH AMERICA
        • THE UNITED STATES
        • CANADA
    1. COMPANY PROFILES
      • COMPETITIVE ANALYSIS
        • MARKET SHARE ANALYSIS
        • TOP COMPANIES
          • ESSILOR INTERNATIONAL S.A. (FRANCE)
          • JOHNSON & JOHNSON INC. (U.S.)
          • ALLERGAN PLC (U.S.)
          • NOVARTIS INTERNATIONAL AG (SWITZERLAND)
          • VALENT PHARMACEUTICALS INTERNATIONAL INC. (U.S.)
        • ALLERGAN INC.
          • COMPANY OVERVIEW
          • PRODUCT & SERVICES
          • SWOT ANALYSIS
          • STRATEGIC INITIATIVES
        • BAYER
          • COMPANY OVERVIEW
          • PRODUCT & SERVICES
          • SWOT ANALYSIS
          • STRATEGIC INITIATIVES
        • CARL ZEISS AG
          • COMPANY OVERVIEW
          • PRODUCT PORTFOLIO
          • SWOT ANALYSIS
          • STRATEGIC INITIATIVE
        • ESSILOR INTERNATIONAL S.A.
          • COMPANY OVERVIEW
          • PRODUCT & SERVICES
          • SWOT ANALYSIS
          • STRATEGIC INITIATIVE
        • GLAXOSMITHKLINE
          • COMPANY OVERVIEW
          • PRODUCT PORTFOLIO
          • SWOT ANALYSIS
        • JOHNSON & JOHNSON INC.
          • COMPANY OVERVIEW
          • PRODUCT PORTFOLIO
          • SCOT ANALYSIS
          • STRATEGIC INITIATIVES
        • NOVARTIS INTERNATIONAL AG
          • COMPANY OVERVIEW
          • PRODUCT PORTFOLIO
          • SCOT ANALYSIS
          • STRATEGIC INITIATIVES
        • PFIZER
          • COMPANY OVERVIEW
          • PRODUCT PORTFOLIO
          • SCOT ANALYSIS
          • STRATEGIC INITIATIVES
        • ROCHE HOLDING AG
          • COMPANY OVERVIEW
          • PRODUCT PORTFOLIO
          • SCOT ANALYSIS
          • STRATEGIC INITIATIVES
        • SANTEN PHARMACEUTICAL CO., LTD.
          • COMPANY OVERVIEW
          • PRODUCT PORTFOLIO
          • SCOT ANALYSIS
          • STRATEGIC INITIATIVE
        • SUN PHARMACEUTICALS INDUSTRIES, LTD
          • COMPANY OVERVIEW
          • PRODUCT PORTFOLIO
          • SCOT ANALYSIS
          • STRATEGIC INITIATIVE
        • VALENT PHARMACEUTICALS INTERNATIONAL INC.
          • COMPANY OVERVIEW
          • PRODUCT PORTFOLIO
          • SCOT ANALYSIS
          • STRATEGIC INITIATIVE
        • ZIEMER GROUP HOLDING AG
          • COMPANY OVERVIEW
          • PRODUCT PORTFOLIO
          • SCOT ANALYSIS
          • STRATEGIC INITIATIVE

     

    LIST OF TABLES

    TABLE 1       NORTH AMERICA OPTHALMOLOGY DRUGS AND DEVICES MARKET 2018-2026

    TABLE 2       PREVALENCE OF EYE DISEASES IN US 2014 & 2030

    TABLE 3       COMMON CAUSES OF LOSS OF VISION IN THE ELDERLY

    TABLE 4       SELECTED LIST OF GLAUCOMA DRUGS IN LATE-STAGE CLINICAL TRIALS

    TABLE 5       EYE DRUGS GONE OFF-PATENT

    TABLE 6       NORTH AMERICA OPTHALMOLOGY DRUGS AND DEVICES MARKET BY DRUGS AND DEVICES 2018-2026 ($ MILLION)

    TABLE 7       NORTH AMERICA DRUGS AND DEVICES MARKET IN DEVICES 2018-2026 ($ MILLION)

    TABLE 8       NORTH AMERICA DEVICES MARKET IN DIAGNOSTIC & MONITORING EQUIPMENT  BY TYPES 2018-2026 ($ MILLION)

    TABLE 9       NORTH AMERICA DIAGNOSTIC & MONITORING EQUIPMENT MARKET IN OPTICAL COHERENCE TOMOGRAPHY 2018-2026 ($ MILLION)

    TABLE 10     NORTH AMERICA DIAGNOSTIC & MONITORING EQUIPMENT MARKET IN OPHTHALMIC ULTRASOUND IMAGING SYSTEMS 2018-2026 ($ MILLION)

    TABLE 11     NORTH AMERICA DIAGNOSTIC & MONITORING EQUIPMENT MARKET IN FUNDUS CAMERA MARKET 2018-2026 ($ MILLION)

    TABLE 12     NORTH AMERICA DIAGNOSTIC & MONITORING EQUIPMENT MARKET IN OPHTHALMOSCOPES 2018-2026 ($ MILLION)

    TABLE 13     NORTH AMERICA DIAGNOSTIC & MONITORING EQUIPMENT MARKET IN RETINOSCOPE 2018-2026 ($ MILLION)

    TABLE 14     NORTH AMERICA DIAGNOSTIC & MONITORING EQUIPMENT MARKET IN PACHYMETER 2018-2026 ($ MILLION)

    TABLE 15     NORTH AMERICA DIAGNOSTIC & MONITORING EQUIPMENT MARKET IN WAVEFRONT ABERROMETERS 2018-2026 ($ MILLION)

    TABLE 16     NORTH AMERICA DIAGNOSTIC & MONITORING EQUIPMENT MARKET IN PERIMETERS/VISUAL FIELD ANALYZER 2018-2026 ($ MILLION)

    TABLE 17     NORTH AMERICA DIAGNOSTIC & MONITORING EQUIPMENT MARKET IN AUTOREFRACTORS/PHOROPTER 2018-2026 ($ MILLION)

    TABLE 18     NORTH AMERICA DIAGNOSTIC & MONITORING EQUIPMENT MARKET IN SPECULAR MICROSCOPE 2018-2026 ($ MILLION)

    TABLE 19     NORTH AMERICA DIAGNOSTIC & MONITORING EQUIPMENT MARKET IN CORNEAL TOPOGRAPHERS 2018-2026 ($ MILLION)

    TABLE 20     NORTH AMERICA DIAGNOSTIC & MONITORING EQUIPMENT MARKET IN OTHER DIAGNOSTIC & MONITORING EQUIPMENT MARKET 2018-2026 ($ MILLION)

    TABLE 21     NORTH AMERICA DEVICES MARKET IN SURGERY DEVICE BY TYPES 2018-2026 ($ MILLION)

    TABLE 22     NORTH AMERICA SURGERY DEVICES MARKET IN CATARACT SURGERY DEVICES 2018-2026 ($ MILLION)

    TABLE 23     NORTH AMERICA SURGERY DEVICES MARKET IN GLAUCOMA SURGERY DEVICES 2018-2026 ($ MILLION)

    TABLE 24     NORTH AMERICA SURGERY DEVICES MARKET IN REFRACTIVE SURGERY DEVICES 2018-2026 ($ MILLION)

    TABLE 25     NORTH AMERICA SURGERY DEVICES MARKET IN VITREORETINAL SURGERY DEVICES 2018-2026 ($ MILLION)

    TABLE 26     NORTH AMERICA DEVICES MARKET IN VISION CARE MARKET 2018-2026 ($ MILLION)

    TABLE 27     NORTH AMERICA DRUGS AND DEVICES MARKET IN DRUGS BY TYPES 2018-2026 ($ MILLION)

    TABLE 28     NORTH AMERICA DRUGS MARKET IN GLAUCOMA DRUG 2018-2026 ($ MILLION)

    TABLE 29     NORTH AMERICA DRUGS MARKET IN RETINAL DISORDER DRUG 2018-2026 ($ MILLION)

    TABLE 30     NORTH AMERICA DRUGS MARKET IN DRY EYE DRUG 2018-2026 ($ MILLION)

    TABLE 31     NORTH AMERICA DRUGS MARKET IN ALLERGIC CONJUNCTIVITIS, INFLAMMATION AND CONJUNCTIVITIS DRUG 2018-2026 ($ MILLION)

    TABLE 32     NORTH AMERICA OPTHALMOLOGY DRUGS AND DEVICES MARKET 2018-2026 ($ MILLION)

     

    LIST OF FIGURES

    FIGURE 1     NORTH AMERICA OPTHALMOLOGY DRUGS AND DEVICES MARKET 2018-2026

    FIGURE 2     NORTH AMERICA DRUGS AND DEVICES MARKET IN DEVICES 2018-2026 ($ MILLION)

    FIGURE 3     NORTH AMERICA DEVICES MARKET DIAGNOSTIC & MONITORING EQUIPMENT IN 2018-2026 ($ MILLION)

    FIGURE 4     NORTH AMERICA DEVICES MARKET IN SURGERY DEVICE 2018-2026 ($ MILLION)

    FIGURE 5     NORTH AMERICA DEVICES MARKET IN VISION CARE MARKET 2018-2026 ($ MILLION)

    FIGURE 6     NORTH AMERICA DRUGS AND DEVICES MARKET IN DRUGS 2018-2026 ($ MILLION)

    FIGURE 7     NORTH AMERICA DRUGS MARKET IN GLAUCOMA DRUG 2018-2026 ($ MILLION)

    FIGURE 8     NORTH AMERICA DRUGS MARKET IN RETINAL DISORDER DRUG 2018-2026 ($ MILLION)

    FIGURE 9     NORTH AMERICA DRUGS MARKET IN DRY EYE DRUG 2018-2026 ($ MILLION)

    FIGURE 10   NORTH AMERICA DRUGS MARKET IN ALLERGIC CONJUNCTIVITIS, INFLAMMATION AND CONJUNCTIVITIS DRUG 2018-2026 ($ MILLION)

    FIGURE 11   NORTH AMERICA OPTHALMOLOGY DRUGS AND DEVICES MARKET 2018-2026 ($ MILLION)

    FIGURE 12   THE UNITED STATES OPTHALMOLOGY DRUGS AND DEVICES MARKET 2018-2026 ($ MILLION)

    FIGURE 13   CANADA OPTHALMOLOGY DRUGS AND DEVICES MARKET 2018-2026 ($ MILLION)

    FIGURE 14   OPHTHALMOLOGY DEVICES COMPANY MARKET SHARE 2017 (%)

    FIGURE 15   OPHTHALMOLOGY DRUGS COMPANY MARKET SHARE 2017 (%)

    1. GEOGRAPHICAL ANALYSIS
      • NORTH AMERICA
        • THE UNITED STATES
        • CANADA
    1. MARKET SEGMENTATION
      • MARKET BY DRUGS AND DEVICES 2018-2026
        • DEVICES
          • DIAGNOSTIC & MONITORING EQUIPMENT
            • OPTICAL COHERENCE TOMOGRAPHY
            • OPHTHALMIC ULTRASOUND IMAGING SYSTEMS
            • FUNDUS CAMERA MARKET
            • OPHTHALMOSCOPES
            • RETINOSCOPE
            • PACHYMETER
            • WAVEFRONT ABERROMETERS
            • PERIMETERS/VISUAL FIELD ANALYZER
            • AUTOREFRACTORS/PHOROPTER
            • SPECULAR MICROSCOPE
            • CORNEAL TOPOGRAPHERS
            • OTHER DIAGNOSTIC & MONITORING EQUIPMENT MARKET
          • SURGERY DEVICE
            • CATARACT SURGERY DEVICES
            • GLAUCOMA SURGERY DEVICES
            • REFRACTIVE SURGERY DEVICES
            • VITREORETINAL SURGERY DEVICES
          • VISION CARE
        • DRUGS
          • GLAUCOMA DRUG
          • RETINAL DISORDER DRUG
          • DRY EYE DRUG
          • ALLERGIC CONJUNCTIVITIS, INFLAMMATION AND CONJUNCTIVITIS DRUG

    To request a free sample copy of this report, please complete the form below :

    We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.


      Choose License Type

      Buy Now